CVS Health Corp. diskutieren
CVS Health Corp.
WKN: 859034 / Symbol: CVS / Name: CVS Health / Aktie / Lebensmittel- & Medikamentenhandel / Large Cap /
67,12 €
-0,47 %
CVS Health (NYSE:CVS) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at Wolfe Research from $85.00 to $100.00. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at Robert W. Baird from $82.00 to $92.00. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at Mizuho from $88.00 to $95.00. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at Truist Financial Corporation from $95.00 to $98.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $93.00 to $95.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at TD Cowen from $100.00 to $105.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at JPMorgan Chase & Co. from $93.00 to $101.00. They now have an "overweight" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target lowered by analysts at Bank of America Corporation from $100.00 to $95.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target lowered by analysts at Argus from $91.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $95.00 to $97.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (CVS) had its price target lowered by Wolfe Research from $100.00 to $97.00. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (CVS) had its "outperform" rating reaffirmed by Leerink Partners.
Ratings data for CVS provided by MarketBeat
Neueste Beiträge
JPMorgan_Chase___Co_ in Marvell Technology Inc. diskutieren